Gts Securities LLC Editas Medicine, Inc. Put Options Transaction History

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$4.67 - $7.28 $26,619 - $41,496
-5,700 Reduced 27.01%
15,400 $71,000
Q1 2024

May 15, 2024
BUY
$7.03 - $11.07 $1,406 - $2,214
200 Added 0.96%
21,100 $156,000
Q4 2023

Feb 14, 2024
SELL
$6.25 - $11.11 $161,875 - $287,749
-25,900 Reduced 55.34%
20,900 $211,000
Q3 2023

Nov 15, 2023
BUY
$6.92 - $9.31 $323,856 - $435,708
46,800 New
46,800 $365,000

Others Institutions Holding EDIT

# of Institutions
247
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $166M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email